The latest closing stock price for Checkpoint Therapeutics as of November 20, 2024 is 3.38.
An investor who bought $1,000 worth of Checkpoint Therapeutics stock at the IPO in 2017 would have $-966 today, roughly -1 times their original investment - a -38.36% compound annual growth rate over 7 years.
The all-time high Checkpoint Therapeutics stock closing price was 100.00 on June 26, 2017.
The Checkpoint Therapeutics 52-week high stock price is 3.97, which is 17.5% above the current share price.
The Checkpoint Therapeutics 52-week low stock price is 1.36, which is 59.8% below the current share price.
The average Checkpoint Therapeutics stock price for the last 52 weeks is 2.24.
An investor who bought $1,000 worth of Checkpoint Therapeutics stock at the IPO in 2017 would have $-966 today, roughly -1 times their original investment - a -38.36% compound annual growth rate over 7 years.
The all-time high Checkpoint Therapeutics stock closing price was 100.00 on June 26, 2017.
The Checkpoint Therapeutics 52-week high stock price is 3.97, which is 17.5% above the current share price.
The Checkpoint Therapeutics 52-week low stock price is 1.36, which is 59.8% below the current share price.
The average Checkpoint Therapeutics stock price for the last 52 weeks is 2.24.